Novel anti-CD3 chimeric antigen receptor targeting of aggressive T cell malignancies

Peripheral T-cell lymphomas (PTCLS) comprise a diverse group of difficult to treat, very aggressive non-Hodgkin's lymphomas (NHLS) with poor prognoses and dismal patient outlook. Despite the fact that PTCLs comprise the majority of T-cell malignancies, the standard of care is poorly established...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Kevin H., Wada, Masayuki, Firor, Amelia E., Pinz, Kevin G., Jares, Alexander, Liu, Hua, Salman, Huda, Golightly, Marc, Lan, Fengshuo, Jiang, Xun, Ma, Yupo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302909/
https://www.ncbi.nlm.nih.gov/pubmed/27494836
http://dx.doi.org/10.18632/oncotarget.11019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302909/
https://www.ncbi.nlm.nih.gov/pubmed/27494836
http://dx.doi.org/10.18632/oncotarget.11019

Ejemplares similares